Top

Reactions Weekly

Published in:

01-01-2023 | Pneumothorax | Case report

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir

Lack of efficacy and off-label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Zaidan N, et al. Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination. Antimicrobial Agents and Chemotherapy 65: e00924-21, No. 11, Nov 2021. Available from: URL: http://doi.org/10.1128/AAC.00924-21

Title: Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir
Lack of efficacy and off-label use: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Pneumothorax
Pneumothorax
Pneumothorax
SARS-CoV-2
Meropenem
Acute Respiratory Distress-Syndrome
COVID-19
Dexamethasone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30578-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir

Lack of efficacy and off-label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Atorvastatin/tozinameran

Digoxin

Atropine/epinephrine/lidocaine

Advice on new safety measures for valproate

COVID-19 vaccines

Multiple drugs